facility

USFDA flags Hetero Labs’ Nakkapalli facility with six serious observations

Hetero Labs' Nakkapalli facility has come under scrutiny after the USFDA identified six major compliance issues, including the use of…

3 weeks ago

Lupine shares jump more than 3% on plans to invest $250 million for new U.S. facility

Shares of drugmaker Lupine Ltd. gained more than 3% on Thursday, October 9, after the company announced plans to establish…

3 weeks ago